SynthesisDrug design, development and therapy2026
Jingtong Granules for Cervicogenic Headache: Clinical Efficacy, Mechanisms, and Translational Potential.
Synthesis in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Headache is a highly prevalent neurological symptom worldwide. Among headache subtypes, cervicogenic headache (CEH) has attracted growing research attention owing to its rising incidence, younger‑onset trend, and substantial adverse impacts on patients' quality of life. However, conventional pharmacological therapies for CEH may be associated with notable adverse effects. Jingtong Granule, a Chinese patent medicine with the functions of promoting blood circulation to remove blood stasis and regulating qi to relieve pain, is widely applied for cervical spondylotic radiculopathy in clinical practice. In recent years, its potential therapeutic value for various headache disorders, particularly CEH, has drawn increasing interest, yet a comprehensive systematic review on this topic remains absent. Based on recent domestic and international studies, this review systematically summarizes the pathogenesis of CEH (especially the relationship between CEH and cervical lesions), the formula characteristics and pharmacological effects of Jingtong Granule, its clinical applications (used either alone or combined with other interventions) for headache management, and its safety profile. Current limitations of available evidence and directions for future research are also highlighted. Notably, existing clinical and mechanistic evidence regarding Jingtong Granule for CEH remains preliminary, and high‑quality, large‑scale clinical trials are still required to support its standardized clinical application. This review aims to provide preliminary references for future clinical use and related investigations of Jingtong Granule in headache treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.